Daunorubicin

Liposomal Daunorubicin & Cytarabine for AML OncLive 1,943 5 лет назад
Daunorubicin and cytarabine approved for AML treatment within NHS Scotland VJHemOnc – Video Journal of Hematology & HemOnc 478 5 лет назад
AML2012 trial: daunorubicin-based induction therapies in pediatric AML VJHemOnc – Video Journal of Hematology & HemOnc 75 10 месяцев назад
DaunoDouble: does increasing daunorubicin dose improve response in AML? VJHemOnc – Video Journal of Hematology & HemOnc 291 6 лет назад
CPX-351: liposomal daunorubicin/cytarabine for AML VJHemOnc – Video Journal of Hematology & HemOnc 328 4 года назад
What is the mechanism of daunorubicin? Medical-Question 1,987 6 лет назад
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML VJHemOnc – Video Journal of Hematology & HemOnc 651 6 лет назад
Doxorubicin; Mechanism of action④ StudyMed 36,948 6 лет назад
Liposomal daunorubicin and cytarabine in R/R ALL VJHemOnc – Video Journal of Hematology & HemOnc 136 3 года назад
CPX-351 liposome injection vs standard cytarabine and daunorubicin for older high-risk AML patients VJHemOnc – Video Journal of Hematology & HemOnc 715 7 лет назад
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults... International Academy for Clinical Hematology IACH 250 3 года назад
AML17 trial update: FLT3-ITD mutation and daunorubicin dosage VJHemOnc – Video Journal of Hematology & HemOnc 317 8 лет назад
CPX-351: Liposomal Cytarabine/Daunorubicin in Secondary AML Targeted Oncology 264 5 лет назад
SAL-DaunoDouble trial: 90 mg vs 60 mg daunorubicin in 7+3 induction for AML VJHemOnc – Video Journal of Hematology & HemOnc 176 4 года назад